In addition, the expression of Smad4 are decreased and largely restricted in the cytoplasm of some of ERα-positive infiltrating human breast cancer cells in contrast to the benign breast tissue in which Smad4 was strongly expressed in both cytoplasm and nucleus of ductal epithelial cells. This evidence concerns the gene ERAL1 and breast cancer.